Status:
UNKNOWN
Botulinum Toxin Injection to Treat Diffuse Esophageal Spasm
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Esophageal Spasm, Diffuse
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study evaluates the effect of botulinum toxin 100 U or saline, injected endoscopically in the distal esophagus, on symptoms and manometry pattern in patients with diffuse esophageal spasm.
Detailed Description
Patients are selected on the basis of a clinical diagnosis of diffuse esophageal spasm, based on endoscopy and manometry. This is a sham-controlled cross-over study of injection of botulinum toxin or...
Eligibility Criteria
Inclusion
- Spastic motor disorder in the upper GI tract
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01432782
Start Date
February 1 2010
End Date
December 1 2013
Last Update
September 13 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven
Leuven, Flanders, Belgium, 3000